SARS-CoV-2 third vaccine immune response in MS patients treated with ocrelizumab

Livnat Brill, Catarina Raposo, Ariel Rechtman, Omri Zveik, Netta Levin, Esther Oiknine-Djian, Dana G. Wolf, Adi Vaknin-Dembinsky
doi: https://doi.org/10.1101/2022.01.26.22269876

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Back to top
Posted January 28, 2022.
Download PDF
Data/Code
Email
SARS-CoV-2 third vaccine immune response in MS patients treated with ocrelizumab
Livnat Brill, Catarina Raposo, Ariel Rechtman, Omri Zveik, Netta Levin, Esther Oiknine-Djian, Dana G. Wolf, Adi Vaknin-Dembinsky
medRxiv 2022.01.26.22269876; doi: https://doi.org/10.1101/2022.01.26.22269876
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area